Aine Dunne
Chief Executive Officer, Process Facilities Group International (PFGi)
Engineering consultancy supports the transition from initial research to large-scale manufacturing, delivering high-quality, safe and efficient design solutions.
In medical research and pharmaceutical development, the transition from early-stage research to large-scale manufacturing is a key aspect of ensuring equitable access to innovative treatments.
Scaling up pharmaceutical manufacturing
While medical innovation and clinical trial evidence lay the groundwork for developing new therapeutic approaches, scaling up production while maintaining safety, efficacy and regulatory compliance can be challenging.
“The scale-up process is as important as it is complex, and the transition to industrial manufacturing requires extensive input,” explains Aine Dunne, Chief Executive Officer of Process Facilities Group International (PFGi). “Our team, with backgrounds in research, development and scale-up, work closely with pharmaceutical and life science companies to streamline this process.”
Tailored engineering solutions
PFGi is an engineering consultancy specialising in design solutions for complex processes. They help to facilitate the transition from initial research to large-scale manufacturing, supporting pharmaceutical companies, contract research organisations and biotech firms to scale up their production.
“We don’t just size equipment; we collaborate with companies to develop entirely new processes or integrate innovations into existing facilities,” says Dunne. “We don’t expect a fully developed process. Our hands-on approach ensures that companies can adapt to the evolving demands of the industry while maintaining efficiency and regulatory compliance.”
With key services such as equipment selection, process mapping and batch manufacturing, the company actively engages in the developmental process, working alongside clients to refine and optimise their production procedures.
As the industry adapts to develop
more niche and high-cost biotech
drugs, manufacturing is key.
Global pharma manufacturing solutions
Working with life science companies globally to commercialise their manufacturing processes, PFGi has offices in Ireland, Eastern Europe, China, India, North America and South America. “We have worked with a number of companies in the US, commercialising their small-scale laboratory process to reach a wider market,” explains Dunne. “As the industry adapts to develop more niche and high-cost biotech drugs, manufacturing is key. We help companies reduce costs and bring drugs to market faster, minimising capital outlay and providing expert guidance throughout each stage of the process.”
She adds: “Sustainability is a core aspect of engineering in commercial pharma, and our CRP [critical resource planning] and SRP [sustainable resource planning] experts can design efficient systems that minimise water usage, ensure energy systems are appropriately sized and consult on the use of alternative energy sources.”
The company prioritises high-quality, safe and efficient design solutions while building lasting, trust-based relationships for successful project outcomes.
To find out more: https://www.processfgi.com/
